LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.59 | 21.74 | 4628 | 4492 | 1.0303 | 1.0078 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.59 | 21.74 | 8 | 4492 | 0.0018 | -0.1219 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 47.59 | 21.74 | 5136 | 4492 | 1.1433 | 1.0351 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 49.56 | 21.74 | 230 | 4838 | 0.0475 | 0.3532 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 49.56 | 21.74 | 4963 | 4838 | 1.0257 | 1.0065 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 49.56 | 21.74 | 4 | 4838 | 0.0008 | -0.1951 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 49.56 | 21.74 | 5430 | 4838 | 1.1222 | 1.0298 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 51.53 | 21.74 | 271 | 5150 | 0.0526 | 0.3769 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 51.53 | 21.74 | 5341 | 5150 | 1.0369 | 1.0092 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 51.53 | 21.74 | 16 | 5150 | 0.0031 | -0.0381 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 51.53 | 21.74 | 5787 | 5150 | 1.1235 | 1.0297 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 53.50 | 21.74 | 269 | 5425 | 0.0496 | 0.3715 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 53.50 | 21.74 | 5760 | 5425 | 1.0616 | 1.0151 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 53.50 | 21.74 | 7 | 5425 | 0.0013 | -0.1326 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 53.50 | 21.74 | 6146 | 5425 | 1.1327 | 1.0315 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 55.48 | 21.74 | 267 | 5768 | 0.0463 | 0.3655 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 55.48 | 21.74 | 6344 | 5768 | 1.0997 | 1.0237 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 55.48 | 21.74 | 27 | 5768 | 0.0047 | 0.0273 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 55.48 | 21.74 | 6872 | 5768 | 1.1912 | 1.0439 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 57.45 | 21.74 | 334 | 6023 | 0.0554 | 0.4003 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 57.45 | 21.74 | 6998 | 6023 | 1.1618 | 1.0373 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 57.45 | 21.74 | 34 | 6023 | 0.0056 | 0.0567 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 57.45 | 21.74 | 7494 | 6023 | 1.2441 | 1.0546 | MN20160310_N01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 59.42 | 21.74 | 402 | 6125 | 0.0656 | 0.4311 | MN20160310_N01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 59.42 | 21.74 | 7577 | 6125 | 1.2370 | 1.0530 | MN20160310_N01 | E21 |